Homepage hero banner background Homepage hero banner background
Breakthrough Mental Healing image

Breakthrough Mental Healing

We help patients unlock the healing power of the mind through Psychedelic Inspired Medicines & Experiential Therapies.

Together we can overcome.

Scroll to the next section on the page
MindMed to Participate at the Benzinga Global Small Cap Conference featured image

MindMed to Participate at the Benzinga Global Small Cap Conference

Advancing Psychedelic-inspired Medicines Through Clinical Trials









MINDMED DEVELOP (Commercial Drug Development Programs)

Anxiety - Project Lucy

Anxiety - Project Lucy



Substance Use Disorders

Substance Use Disorders


LSD Microdosing

Adult ADHD

Adult ADHD


MINDMED DISCOVER (R&D Collaborations)

University Hospital Basel

LSD Assisted Therapy

Cluster Headaches

Multiple Ongoing or Completed:
 on LSD, MDMA, DMT, Psilocybin

LSD Assisted Therapy


Cluster Headaches


Multiple Ongoing or Completed:
 on LSD, MDMA, DMT, Psilocybin


Home hero image man sleeping background
Abstract Background Abstract background
Home hero image man sleeping foreground

We’re a New Kind of Pharma Company

Patients and therapists deserve care that transcends traditional symptom management cycles, advancing long-term mental healing.

View our approach

Our Healing Goes Beyond Just A Pill



Rigorous science of novel psychedelic compounds, therapies, and healing technologies in collaboration with leading institutions and researchers to make faster discoveries, together



Conducting clinical trials of psychedelic inspired medicines and experiential therapies within existing regulatory pathways to ensure the most effective & transformative healing experience possible



We hold ourselves and our products to the highest levels of safety, efficacy, and accessibility so psychedelic inspired medicines and experiential therapies can one day reach patients in need

Quotation Marks

This could save lives, cure depression, help alcoholism, get people off opioids—why wouldn’t I want to be invested?”

Shark Tank's Kevin O' Leary MindMed Investor

MindMed named one of 36 startups that could change the world

MindMed could have the key to providing the upsides of psychedelic drugs for both focus and addiction treatment—while cutting out the downsides of tripping.”

We have the right people for the right reasons.

Our interdisciplinary team of drug development veterans, savvy technologists, and mental health experts was purpose-built to tackle these challenges. With over a century of combined experience in product development and commercialization, we have the know-how and the heart to introduce a better approach to mental health.

Scroll team widget background

Robert Barrow

Chief Executive Officer

Daniel R Karlin, MD MA

Chief Medical Officer

Miri Halperin Wernli, PhD

Executive President and Board Director

Bradford Cross

Chief Technology Officer

Donald Gehlert, PhD

Chief Scientific Officer

Dave Guebert

Chief Financial Officer

Maurizio Fava, MD

Member, Scientific Advisory Board Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Malenka, MD PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Bryan L. Roth, MD, PhD

Professor of Pharmacology, University of North Carolina School of Medicine; Director of the National Institute of Mental Health Psychoactive Drug Screening Program

Maria A. Oquendo, M.D., Ph.D.

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Stanley D Glick, MD PhD

Scientific Advisor

Natalie Wheeler, PhD

Medical Science Liaison with Dova Pharmaceuticals

Carrie Liao, CPA

VP, Corporate Controller & Accounting Principal

Kenneth Alper, MD

Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine

Sarah McCallum, PhD

Associate Professor of Neuroscience and Experimental Therapeutics (DNET) at Albany Medical College

John Rotrosen, MD

Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry

Matthew W Johnson, PhD

Clinical Advisor

Peter Gasser, MD

Clinical Advisor

Photo of Professor Dr. Matthias Liechti, PhD & M.D.

Matthias Liechti, MD PhD

Scientific Collaborator & Advisor

Photo of Dr. Kim Kuypers PhD

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Sarah Y Vinson, MD

Board Director, Member of Compensation, Nomination, and Governance Committees

Brigid Makes

Board Director, Chair of Audit/Finance Committee, Member of Compensation, Nomination, and Governance Committees

Perry Dellelce

Board Chairman

Stephen L. Hurst, JD

Co-Founder and Board Director

Andreas Krebs

Board Director, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee

Carol Vallone

Board Director, Chair of Compensation Committee, Member of Audit/Finance Committee

JR Rahn


Scott Freeman, MD

Co-Founder & Clinical Advisor

Leonard Latchman


Shahera St. John

VP, Programs

Peter Mack, PhD

VP, Pharmaceutical Development

Nico Forte

VP, Business Operations and Development

Carole Abel

VP, EU Operations & Alliances, and Program Leader LSD

Jakub Klimes

VP, Global Operations

Carol Gaines, MD

Senior Medical Director

Stephen Schneider, PhD

Sr. Director, Drug Substance Development

Lysa Triantafillou

Senior Director of Clinical Quality Assurance

Jamie Freedman

Director of Clinical Operations

Madeline Feldman

Director of Strategy & Operations

Julie Tripp

Director of Toxicology

Jamileh Jemison, MD

Digital Clinical Director

Kristopher Justo

Director of IT

Todd Solomon, PhD

Digital Clinical Director

Martin Majernik

Director of Digital Product Lifecycle

Gennady Smagin

Director of Pharmacology

Amber Doty

Director of Pharmaceutical Development

Dustin Melton

Director of Pharmaceutical Development

Craig Conant

Associate Director, Clinical Operations

Sarah Karas

Associate Director, Clinical Science

Matus Hajduk

Sr Clinical Operations Manager

Alex Deschamps

Clinical Research Coordinator

Shenique Gardner

Shenique Gardner

Clinical Research Coordinator

Ezekiel Powdar

Clinical Research Coordinator

Cordia Simmons

Clinical Trial Assistant

Georgios Lampadariou

Senior Product Manager

Dana Rajtarova

Senior Business Development Manager

Ondrej Skala

Associate Project Manager

Sarah Chrisant

Associate Manager, QMS

Tomas Stefanicka

Infrastructure Lead

Peter Dubec

Product Engineering Lead

Alexander Wald

iOS Engineer

Adam Kolar

Machine Learning Lead

Miguel Amável Pinheiro, PhD

Machine Learning Lead

Martin Pilch

Senior iOS Engineer

Branislav Rariga

Senior Designer

Michal Lietava

Sr Finance Manager

Jon Polaha

Financial Analyst

Enriko Malinak

Sr Legal Specialist

Alena Vankova

Talent & People Ops Specialist

Daniel Gavin

Senior Recruiter

Klara Kleinova

People & Business Ops Specialist

Wenna Wu

People & Business Ops Generalist

Michal Trebula

Finance Specialist

Libby McLean

Libby McLean

Junior Research & Operations Specialist